Safety of the Rifampin and Pyrazinamide Short-Course Regimen for Treating Latent Tuberculosis Infection

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2007-02, Vol.44 (3), p.464-465
Hauptverfasser:	Ijaz, Kashef, McElroy, Peter D., Jereb, John, Navin, Thomas R., Castro, Kenneth G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antitubercular Agents - adverse effects Communicable disease control Correspondence Death Drug Administration Schedule Hepatotoxicity Humans Infectious diseases Latent tuberculosis Liver Liver - drug effects Liver - pathology Physical trauma Practice Guidelines as Topic Pyrazinamide - adverse effects Recommendations Rifampin - adverse effects Thoracic diseases Treatment Outcome Tuberculosis Tuberculosis - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!